STOCK TITAN

10x Genomics: T. Rowe Price reports 14.5% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

10x Genomics, Inc. (TXG) shares are the subject of T. Rowe Price Associates, Inc.'s amended ownership report. As of September 30, 2026, T. Rowe Price Associates reported beneficial ownership of 17,472,941 shares, or 14.5% of the class, with sole voting power over 16,779,529 shares and sole dispositive power over 17,472,941 shares. The entity expressly stated that the report is not an admission that it is the beneficial owner of the securities.

Reported beneficial ownership 17,472,941 shares 10x Genomics common stock; event date September 30, 2026
Percent of class 14.5% Reported beneficial ownership as of September 30, 2026
Sole voting power 16,779,529 shares 10x Genomics common stock
Sole dispositive power 17,472,941 shares 10x Genomics common stock
beneficial ownership financial
"amount beneficially owned: 17,472,941"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
sole voting power financial
"sole power to vote or to direct the vote"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power financial
"sole power to dispose or to direct the disposition"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TXG shares did T. Rowe Price Associates report?

T. Rowe Price Associates, Inc. reported beneficial ownership of 17,472,941 shares of 10x Genomics common stock, equal to 14.5% of the class as of September 30, 2026. It expressly denied that the report should be construed as an admission that it is the beneficial owner.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





88025U109

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



T. Rowe Price Associates, Inc.
Signature:Ellen York
Name/Title:Vice President
Date:11/16/2026

Keep reading